Unusual MR spectroscopic imaging pattern of an astrocytoma: Lack of elevated choline and high myo-inositol and glycine levels

American Journal of Neuroradiology

Volumn 24, Issue 5, 2003, Pages 942-945

  Londoño, Ana ^b   Castillo, Mauricio ^a   Armao, Diane ^b   Kwock, Lester ^b   Suzuki, Kinuko ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CASE REPORT; DIAGNOSTIC IMAGING; FRONTAL LOBE; HUMAN; IMAGE ANALYSIS; INSULA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHOLINE; GLYCINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 0038178153     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Piepmier JM, Fried I, Makuch R. Low-grade astrocytomas may arise from different astrocyte lineage. Neurosurgery 1993;33:627-632
2. Miller R, Raff M. Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. J Neurosci 1984;4:585-592
3. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645-1649
4. Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 2000;42:333-338
5. Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516-524
6. Miller BL, Chang L, Booth R, et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58:1929-1935
7. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989
8. Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MRS spectroscopy. AJNR Am J Neuroradiol 1999;20:1619-1627
9. Danielsen ER, Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: Marcel Decker; 1999:34
10. Verleysdonk S, Martin H, Willker W, Leibfritz D, Hamprecht B. Rapid uptake and degradation of glycine by astroglial cells in culture: synthesis and release of serine and lactate. Glia 1999;27:239-248
11. Gutowski NJ, Gomez-Anson B, Torpey N, Revesz T, Miller D, Rudge P. Oligodendroglial gliomatosis cerebri: (1)H-MRS suggests elevated glycine/inositol levels. Neuroradiology 1999;41:650-653
12. Esteve F, Grand S, Rubin C, et al. MR spectroscopy of bilateral thalamic gliomas. AJNR Am J Neuroradiol 1999;20:876-881
13. Schabel FM. The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors. Cancer Res 1969;29:2384-2389
14. Dirks PB, Rutka JT. Currents concepts in neuro-oncology: the cell cycle. Neurosurgery 1997;40:1000-1015
15. Podo F. Tumour phospholipids metabolism review article. NMR Biomed 1999;12:413-439
16. Watanabe T, Nakamura M, Kros JM, et al. Phenotypes versus genotype correlation in oligodendrogliomas and low grade diffuse astrocytomas. Acta Neuropathol (Berl) 2002;103:2671-2675
17. Krouwer HG, David RL, Silver P, Prados M. Gemistocytic astrocytomas: a reappraisal. J Neurosurg 1991;74:399-406
18. Watanabe K, Tachibana O, Yonekawa Y. Role of gemistocytes in astrocytoma progression. Lab Invest 1997;76:277-284
19. Paulus W, Grothe C, Sensenbrenner M, et al. Localization of basic fibroblast growth factor: a mitogen and angiogenic factor in human brain tumors. Acta Neuropathol (Berl) 1990;79:418-423